Navigation Links
Clinical Laboratory Management Association's ThinkLab '10 Surpasses Attendance Goals
Date:6/29/2010

CHICAGO, June 29 /PRNewswire/ -- The Clinical Laboratory Management Association (CLMA) is pleased to announce the success of ThinkLab '10, the association's annual meeting, with a 30% increase in attendance and more than 30 new exhibitors.

"ThinkLab '10 surpassed our expectations on all fronts. With robust educational offerings and a packed Exhibit Hall, the event provided attendees with a top-notch professional development opportunity and the chance to meet industry-leading vendors," said C. Anne Pontius, CLMA president. "The post-ThinkLab energy and enthusiasm has been infectious, and I look forward to the continued evolution of our programs and offerings through the rest of this year and beyond."

ThinkLab '10, which was sponsored by Orchard Software, marked the introduction of the CLMA Body of Knowledge for Clinical Laboratory Management, representing the comprehensive set of skills necessary to be a competent laboratory manager. The content of the Body of Knowledge for Clinical Laboratory Management supported the educational offering at ThinkLab '10 and will drive future CLMA educational programming.

Highlights from the post-conference attendee evaluation include:

"This is one of the most informative laboratory meetings that I have been to. There are lots of seminars to choose from and every one that I went to had information that I could take back to my lab and use. Not once did I feel like I was wasting company money!"

"CLMA ThinkLab is a wonderful opportunity to 'recharge your batteries.' It provides many avenues for networking, and the educational programs are excellent. I wish all my managers could attend!"

CLMA will continue the tradition at ThinkLab '11, taking place May 2011 at the Baltimore Convention Center in Baltimore, Maryland. Visit www.clma.org for additional details.

About the Clinical Laboratory Management Association

Founded in 1976, CLMA is an international association of 3,400 clinical laboratory professionals. The association provides leadership in the clinical laboratory industry supporting laboratory professionals through all stages of their careers. CLMA educates and advocates on behalf of its members and plays a leadership role in enhancing the image and increasing the visibility of its profession. CLMA's Vision: CLMA is the premier resource for laboratory professionals, supporting them at any stage of their career. CLMA's Mission: CLMA empowers laboratory professionals to achieve excellence in leadership through forward-thinking educational, networking and advocacy opportunities. For more information, please visit www.clma.org.


'/>"/>
SOURCE Clinical Laboratory Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
2. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
3. Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound
4. Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study
5. Stemedica Announces the Appointment of Dr. Lev Verkh as Chief Regulatory and Clinical Development Officer
6. Open Source Clinical Trials Software Featured at the 46th DIA Annual Meeting
7. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
8. New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting
9. NewLink Initiates Pivotal Phase 3 Clinical Trial of HyperAcute(R)-Pancreas Immunotherapy for Resected Pancreatic Cancer
10. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
11. Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  OncoSec Medical ... cancer immunotherapies, will host a Key Opinion Leader event ... as an oral and poster presentation at the upcoming ... plan. The KOL event will be held in-person and ... PM EST / 9:00 AM PST at the Lotte ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
Breaking Biology Technology:
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):